PT3603621T - Lipossomas para o tratamento de doenças oculares - Google Patents

Lipossomas para o tratamento de doenças oculares

Info

Publication number
PT3603621T
PT3603621T PT191890789T PT19189078T PT3603621T PT 3603621 T PT3603621 T PT 3603621T PT 191890789 T PT191890789 T PT 191890789T PT 19189078 T PT19189078 T PT 19189078T PT 3603621 T PT3603621 T PT 3603621T
Authority
PT
Portugal
Prior art keywords
liposomes
treatment
ocular diseases
ocular
diseases
Prior art date
Application number
PT191890789T
Other languages
English (en)
Original Assignee
Tdc Tech Dedicated To Care S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tdc Tech Dedicated To Care S R L filed Critical Tdc Tech Dedicated To Care S R L
Publication of PT3603621T publication Critical patent/PT3603621T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1276—Globules of milk; Constituents thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT191890789T 2018-07-31 2019-07-30 Lipossomas para o tratamento de doenças oculares PT3603621T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102018000007677A IT201800007677A1 (it) 2018-07-31 2018-07-31 Liposomi per il trattamento di patologie oculari

Publications (1)

Publication Number Publication Date
PT3603621T true PT3603621T (pt) 2025-05-14

Family

ID=63965859

Family Applications (1)

Application Number Title Priority Date Filing Date
PT191890789T PT3603621T (pt) 2018-07-31 2019-07-30 Lipossomas para o tratamento de doenças oculares

Country Status (6)

Country Link
US (1) US10835494B2 (pt)
EP (1) EP3603621B1 (pt)
ES (1) ES3024689T3 (pt)
IT (1) IT201800007677A1 (pt)
PL (1) PL3603621T3 (pt)
PT (1) PT3603621T (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230190652A1 (en) 2020-04-16 2023-06-22 Dermopartners,S.L. Composition for the treatment of covid-19 and treatment method
IT202000009430A1 (it) 2020-04-29 2021-10-29 Tdc Tech Dedicated To Care Srl Composizione per la prevenzione e/o il trattamento delle infezioni delle vie respiratorie
US11833224B1 (en) 2023-02-08 2023-12-05 Leuvian Llc Lyoprotectant compositions and uses thereof
AR131918A1 (es) * 2023-02-22 2025-05-14 Lactea Therapeutics Llc Composiciones de lactoferrina purificada y métodos de uso
IT202300024966A1 (it) * 2023-11-23 2025-05-23 Offhealth Spa Collirio a base di liposomi di lattoferrina con vit. e tpgs e stearilamina, per il trattamento di malattie oculari

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2284398B2 (es) * 2006-04-27 2008-12-16 Universidad Complutense De Madrid Formulacion de vesiculas liposomales en soluciones acuosas con caracteristicas de pelicula lagrimal.
US20120003296A1 (en) * 2010-07-01 2012-01-05 Shantha Totada R New methods of treating dry eye syndrome

Also Published As

Publication number Publication date
US20200046641A1 (en) 2020-02-13
EP3603621A1 (en) 2020-02-05
US10835494B2 (en) 2020-11-17
PL3603621T3 (pl) 2025-06-16
IT201800007677A1 (it) 2020-01-31
EP3603621B1 (en) 2025-02-19
ES3024689T3 (en) 2025-06-05

Similar Documents

Publication Publication Date Title
IL276383B1 (en) Treatment of ophthalmological diseases
IL277333A (en) Methods for treating eye diseases
IL278178A (en) Use of pilocarpine hydrochloride to treat eye disorder
IL289405A (en) Personalized treatment of eye diseases
PL3603621T3 (pl) Liposomy do leczenia chorób oczu
IL287280A (en) Compounds and methods for the treatment of ocular disorders
IL268357A (en) Photoreceptor cells for the treatment of retinal diseases
ZA201607260B (en) Compounds for treating ophthalmic diseases and disorders
SG11202006374VA (en) Treatment of demyelinating diseases
ZA202006234B (en) Compositions and methods for the treatment of neurological diseases
IL282643A (en) Soft combinations for the treatment of hematological diseases
IL282360A (en) Treatment for neurological diseases
GB201805100D0 (en) Treatment of sarcopenic diseases
IL287264A (en) Compounds and methods for the treatment of ocular disorders
EP3675889A4 (en) ANGIO -3 FOR THE TREATMENT OF ANGIOGENIC RETINAL DISEASES
PL3761982T3 (pl) Zastosowanie nalfurafiny w leczeniu chorób demielinizacyjnych
PT3619204T (pt) Compostos para o tratamento de doenças respiratórias
PL3407879T3 (pl) Gabapentyna okulistyczna do leczenia wrzodów rogówki
GB201914516D0 (en) Treatment of eye disease
IL263837A (en) Treatment of ocular disease
GB2603379B (en) Avocatin B for the treatment of diseases and conditions
GB201909438D0 (en) Treatment of diseases
HK40061035A (en) Novel compounds for the treatment of respiratory diseases
HK40059587A (en) Combination therapy for treatment of hematological diseases
AU2018904241A0 (en) Novel compounds for the treatment of respiratory diseases